Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Minerva Neurosciences Inc. (NERV)

8.93   -0.07 (-0.78%) 02-21 16:00
Open: 9 Pre. Close: 9
High: 9.14 Low: 8.83
Volume: 185,932 Market Cap: 348M
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.149 - 9.199 9.199 - 9.241
Low: 8.71 - 8.772 8.772 - 8.823
Close: 8.836 - 8.931 8.931 - 9.01

Technical analysis

as of: 2020-02-21 4:32:21 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.17     One year: 13.04
Support: Support1: 8.36    Support2: 7.62
Resistance: Resistance1: 9.56    Resistance2: 11.17
Pivot: 8.62
Moving Average: MA(5): 8.99     MA(20): 8.50
MA(100): 6.50     MA(250): 6.73
MACD: MACD(12,26): 0.32     Signal(9): 0.31
Stochastic oscillator: %K(14,3): 71.85     %D(3): 80.09
RSI: RSI(14): 59.48
52-week: High: 9.56  Low: 4.01  Change(%): 9.4
Average Vol(K): 3-Month: 39690  10-Days: 27276

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NERV has closed below upper band by 25.9%. Bollinger Bands are 40% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 19 Dec 2019 18:30:21 +0000
Health Care Sector Update for 12/19/2019: AXSM,PRTK,NERV

Thu, 19 Dec 2019 20:58:37 +0000
Health Care Sector Update for 12/19/2019: NDRA,AXSM,PRTK,NERV

Fri, 20 Dec 2019 01:54:48 +0000
FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed

Thu, 19 Dec 2019 14:20:05 +0000
Health Care Sector Update for 12/19/2019: PRTK, RAD, NERV, JNJ, PFE, ABT, MRK, AMGN

Sat, 05 Oct 2019 17:00:00 +0000
These 2 Neuroscience Stocks Have Tanked as Much as 33% Since September 1. Are They Buys?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 39.03
Shares Float (M) 37.47
% Held by Insiders 3.87
% Held by Institutions 83.39
Shares Short (K) 3100
Shares Short P. Month (K)

Stock Financials

EPS -1.420
Book Value (p.s.) 1.420
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -27.3
Return on Equity (ttm) -70.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.463
Qtrly Earnings Growth
Operating Cash Flow (M) -39.05
Levered Free Cash Flow (M) -18.49

Stock Valuations

P/E -6.29
P/E Growth Ratio -0.01
P/BV 6.29
P/CF -8.93

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.